Malignant mediastinal mass, also known as mediastinal malignant tumor, is a malignant disease that occurs within the mediastinal tissue, including various types such as neurofibromatosis and thymic carcinoma. The mediastinum is located between two lungs and contains a large number of important structures such as blood vessels, trachea, esophagus, nerves, and lymph nodes. Therefore, malignant tumors in this area pose a serious threat to human health.
Symptom manifestations
The symptoms of malignant mediastinal masses may include chest pain, tightness, cough, difficulty breathing, and radiation pain, which may be caused by the tumor's infiltration and compression of surrounding tissues.
therapeutic method
The treatment of malignant mediastinal masses requires comprehensive consideration of the tumor type, size, location, and overall health status of the patient. The treatment methods mainly include the following:
Surgical treatment: For early and localized tumors, surgical resection is the preferred treatment method. Surgery can be performed through thoracotomy or minimally invasive methods to remove tumors as completely as possible. Postoperative adjuvant chemotherapy or radiotherapy may also be necessary to prevent recurrence.
Radiotherapy: Radiotherapy is a treatment method that uses high-energy radiation to kill cancer cells. It can serve as both an adjuvant therapy after surgery and a primary treatment for patients who are unable to undergo surgery. Radiotherapy can reduce tumor size, alleviate symptoms, and prevent further tumor spread.
Chemotherapy: Chemotherapy is a systemic treatment strategy that uses chemical drugs to kill rapidly proliferating cancer cells. It is suitable for patients with chronic diseases or those who are not suitable for radical treatment. Chemotherapy drugs reach various parts of the body through the bloodstream and can kill distant tumor cells.
Targeted therapy: Drug therapy targeting specific tumor molecular markers is called targeted therapy. This treatment method can selectively block the cancer growth signaling pathway, thereby enhancing efficacy and reducing damage to normal cells.
Immunotherapy: Immunotherapy recognizes and attacks tumor cells by activating the patient's own immune system. It may bring long-term relief effects to certain types of malignant tumors.
matters needing attention
The treatment of malignant mediastinal masses is individualized, and doctors will develop the best treatment plan based on the specific situation of the patient. Patients should maintain a positive attitude during the treatment process and follow medical advice for regular follow-up to monitor changes in their condition. At the same time, patients should also pay attention to maintaining good lifestyle and dietary habits to improve their body's ability to resist diseases.
ViDia Hospital Karlsruhe
On Request
3 Day
Hospitalized
ViDia Hospital Karlsruhe
23,078.20 EUR
10 Day
Hospitalized
ViDia Hospital Karlsruhe
7,653.70 EUR
5 Day
Outpatient
ViDia Hospital Karlsruhe
24,625.10 EUR
39 Day
Outpatient
University Hospital Ulm
On Request
3 Day
Hospitalized
University Hospital Ulm
26,059.86 EUR
10 Day
Hospitalized
University Hospital Ulm
8,577.64 EUR
5 Day
Outpatient
University Hospital Ulm
29,311.62 EUR
39 Day
Outpatient
University Hospital Frankfurt am Main
4,627.75 EUR
3 Day
Hospitalized
University Hospital Frankfurt am Main
24,092.97 EUR
10 Day
Hospitalized
University Hospital Frankfurt am Main
8,163.18 EUR
5 Day
Outpatient
University Hospital Frankfurt am Main
24,512.35 EUR
39 Day
Outpatient
University Hospital Tuebingen
On Request
3 Day
Hospitalized
University Hospital Tuebingen
25,961.73 EUR
10 Day
Hospitalized
University Hospital Tuebingen
8,307.25 EUR
5 Day
Outpatient
University Hospital Tuebingen
29,423.33 EUR
39 Day
Outpatient
University Hospital RWTH Aachen
4,927.38 EUR
3 Day
Hospitalized
University Hospital RWTH Aachen
27,646.74 EUR
10 Day
Hospitalized
University Hospital RWTH Aachen
8,709.19 EUR
5 Day
Outpatient
University Hospital RWTH Aachen
30,890.15 EUR
39 Day
Outpatient